Torben Højland
University of Southern Denmark
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Torben Højland.
Nucleic Acids Research | 2009
Jesper B. Bramsen; Maria B. Laursen; Anne F. Nielsen; Thomas B. Hansen; Claus Bus; Niels Langkjær; B. Ravindra Babu; Torben Højland; Mikhail Abramov; Arthur Van Aerschot; Dalibor Odadzic; Romualdas Smicius; Jens Haas; Cordula Andree; J. M. Barman; Malgorzata Wenska; Puneet Srivastava; Chuanzheng Zhou; Dmytro Honcharenko; Simone Hess; Elke Müller; Georgii V. Bobkov; Sergey N. Mikhailov; Eugenio Fava; Thomas F. Meyer; Jyoti Chattopadhyaya; Marino Zerial; Joachim W. Engels; Piet Herdewijn; Jesper Wengel
The use of chemically synthesized short interfering RNAs (siRNAs) is currently the method of choice to manipulate gene expression in mammalian cell culture, yet improvements of siRNA design is expectably required for successful application in vivo. Several studies have aimed at improving siRNA performance through the introduction of chemical modifications but a direct comparison of these results is difficult. We have directly compared the effect of 21 types of chemical modifications on siRNA activity and toxicity in a total of 2160 siRNA duplexes. We demonstrate that siRNA activity is primarily enhanced by favouring the incorporation of the intended antisense strand during RNA-induced silencing complex (RISC) loading by modulation of siRNA thermodynamic asymmetry and engineering of siRNA 3′-overhangs. Collectively, our results provide unique insights into the tolerance for chemical modifications and provide a simple guide to successful chemical modification of siRNAs with improved activity, stability and low toxicity.
Advances in Genetics | 2013
Karin E. Lundin; Torben Højland; Bo Hansen; Robert Persson; Jesper B. Bramsen; Jørgen Kjems; Troels Koch; Jesper Wengel; C. I. Edvard Smith
Locked nucleic acid (LNA) is one of the most promising new nucleic acid analogues that has been produced under the past two decades. In this chapter, we have tried to cover many of the different areas, where this molecule has been used to improve the function of synthetic oligonucleotides (ONs). The use of LNA in antisense ONs, including gapmers, splice-switching ONs, and siLNA, as well as antigene ONs, is reviewed. Pharmacokinetics as well as pharmacodynamics of LNA ONs and a description of selected compounds in, or close to, clinical testing are described. In addition, new LNA modifications and the adaptation of enzymes for LNA incorporation are reviewed. Such enzymes may become important for the development of stabilized LNA-containing aptamers.
Nucleic Acids Research | 2011
Joan Skov; Torsten Bryld; Dorthe Lindegaard; Katrine E. Nielsen; Torben Højland; Jesper Wengel; Michael Petersen
We report the synthesis of two C4′-modified DNA analogues and characterize their structural impact on dsDNA duplexes. The 4′-C-piperazinomethyl modification stabilizes dsDNA by up to 5°C per incorporation. Extension of the modification with a butanoyl-linked pyrene increases the dsDNA stabilization to a maximum of 9°C per incorporation. Using fluorescence, ultraviolet and nuclear magnetic resonance (NMR) spectroscopy, we show that the stabilization is achieved by pyrene intercalation in the dsDNA duplex. The pyrene moiety is not restricted to one intercalation site but rather switches between multiple sites in intermediate exchange on the NMR timescale, resulting in broad lines in NMR spectra. We identified two intercalation sites with NOE data showing that the pyrene prefers to intercalate one base pair away from the modified nucleotide with its linker curled up in the minor groove. Both modifications are tolerated in DNA:RNA hybrids but leave their melting temperatures virtually unaffected. Fluorescence data indicate that the pyrene moiety is residing outside the helix. The available data suggest that the DNA discrimination is due to (i) the positive charge of the piperazino ring having a greater impact in the narrow and deep minor groove of a B-type dsDNA duplex than in the wide and shallow minor groove of an A-type DNA:RNA hybrid and (ii) the B-type dsDNA duplex allowing the pyrene to intercalate and bury its apolar surface.
PLOS ONE | 2014
Vasanthanathan Poongavanam; Praveen K. Madala; Torben Højland; Rakesh N. Veedu
Aptamers constitute a potential class of therapeutic molecules typically selected from a large pool of oligonucleotides against a specific target. With a scope of developing unique shorter aptamers with very high biostability and affinity, locked nucleic acid (LNA) nucleotides have been investigated as a substrate for various polymerases. Various reports showed that some thermophilic B-family DNA polymerases, particularly KOD and Phusion DNA polymerases, accepted LNA-nucleoside 5′-triphosphates as substrates. In this study, we investigated the docking of LNA nucleotides in the active sites of RB69 and KOD DNA polymerases by molecular docking simulations. The study revealed that the incoming LNA-TTP is bound in the active site of the RB69 and KOD DNA polymerases in a manner similar to that seen in the case of dTTP, and with LNA structure, there is no other option than the locked C3′-endo conformation which in fact helps better orienting within the active site.
Højland, T., Veedu, R.N. <http://researchrepository.murdoch.edu.au/view/author/Veedu, Rakesh.html>, Vester, B. and Wengel, J. (2012) Enzymatic synthesis of DNA strands containing α-L-LNA (α-L-configured locked nucleic acid) thymine nucleotides. Artificial DNA: PNA & XNA, 3 (1). pp. 14-21. | 2012
Torben Højland; Rakesh N. Veedu; Birte Vester; Jesper Wengel
We describe the first enzymatic incorporation of an α-L-LNA nucleotide into an oligonucleotide. It was found that the 5′-triphosphate of α-L-LNA is a substrate for the DNA polymerases KOD, 9°Nm, Phusion and HIV RT. Three dispersed α-L-LNA thymine nucleotides can be incorporated into DNA strands by all four polymerases, but they were unable to perform consecutive incorporations of α-L-LNA nucleotides. In addition it was found that primer extension can be achieved using templates containing one α-L-LNA nucleotide.
Bioorganic & Medicinal Chemistry Letters | 2008
Birte Vester; Anne Marie Boel; Sune Lobedanz; B. Ravindra Babu; Michael Raunkjær; Dorthe Lindegaard; Raunak; Patrick J. Hrdlicka; Torben Højland; Pawan K. Sharma; Surender Kumar; Poul Nielsen; Jesper Wengel
Ten different chemically modified nucleosides were incorporated into short DNA strands (chimeric oligonucleotides ON3-ON12 and ON15-ON24) and then tested for their capacity to mediate RNAse H cleavage of the complementary RNA strand. The modifications were placed at two central positions directly in the RNase H cleaving region. The RNA strand of duplexes with ON3, ON5 and ON12 were cleaved more efficiently than the RNA strand of the DNA:RNA control duplex. There seems to be no correlation between the thermal stability between the duplexes and RNase H cleavage.
Nucleosides, Nucleotides & Nucleic Acids | 2007
Torben Højland; Bolle Ravindra Babu; Torsten Bryld; Jesper Wengel
We present our studies on the ability of several different nucleotide analogs as triplex-forming oligonucleotides. The modifications tested include 4′-C-hydroxymethyl, LNA, 2′-amino-LNA and N2′-functionalized 2′-amino-LNA. Triplexes containing monomers of N2′-glycyl-functionalized 2′-amino-LNA are particularly stable.
New conformationally restricted DNA mimics | 2008
Torben Højland; B. Ravindra Babu; Jesper Wengel
Two novel bicyclic nucleotide monomers have been developed for use as DNA mimics. Melting temperature studies showed that these modifications decrease binding affinity towards complementary DNA and RNA.
Molecular BioSystems | 2009
Kees Fluiter; Olaf R. Mook; Jeroen Vreijling; Niels Langkjær; Torben Højland; Jesper Wengel; Frank Baas
Organic and Biomolecular Chemistry | 2007
Torben Højland; Surender Kumar; B. Ravindra Babu; Tadashi Umemoto; Nanna Albæk; Pawan K. Sharma; Poul Nielsen; Jesper Wengel